Glenmark Life Sciences Ltd Share - Know Your Stock (KYS) | Research 360 by Motilal Oswal
logo
Login or Signup
12:49 May 18

Glenmark Life Sciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
822.55
-11.45 (-1.37%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Glenmark Life Sciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 12:49 May 18
Up
822.55
-11.45 (-1.37%)
image/svg+xml

52/100 Medium Financial Strength

Quality
image/svg+xml

39/100 Mid Valuation

Valuation

60/100 Technically Neutral

Technical

SWOT

Strength

6

Weakness

3

Opportunity

1

Threat

1

10.08K

Market Cap (Cr)

21.40

PE Ratio

4.38

Price to Book Ratio

51.64

RSI

0.00 %

Net Profit Margin

Rating Based on 2 Analysts

Buy 50%
Hold 50%
Sell 0%
Buy
The consensus recommendation from 1 analysts for Glenmark Life Sciences Ltd. is Buy

Analyst Price Target

The average price target is 915 with a high estimate of 1040 and low estimate of 790
Current 822.55
1040.00
915.00
790.00
Disclaimer:The analysis information is for reference only and does not constitute an investment recommendation

SWOT

Take your research to the next level.
Login now to unlock Exclusive Features!

logo

Download Our App On: